Bortezomib/SBE-β-cyclodextrin inclusion complex for improved anticancer performance: formulation, characterization, and biological evaluation

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY · Published 2026-05-28 · DOI 10.1080/10837450.2026.2673573

Authors (8)

Saber Hakiminasab, Mohammad Mashreghi, Bizhan Malaekeh-Nikouei, Seyedeh Hoda Alavizadeh, Shiva Golmohammadzadeh, Leila Arabi, Fatemeh Akbarzadeh-Ebrahimi, Mahmoud Reza Jaafari

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Hakiminasab, S., Mashreghi, M., Malaekeh-Nikouei, B., et al. (2026). Bortezomib/SBE-β-cyclodextrin inclusion complex for improved anticancer performance: formulation, characterization, and biological evaluation. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. https://doi.org/10.1080/10837450.2026.2673573

Related articles